NCT07323420

Brief Summary

This observational study aims to evaluate the effects of different inspiratory to expiratory (I:E) ratios (1:2 vs. 1:3) during mechanical ventilation in pediatric patients undergoing dental procedures under general anesthesia. Due to behavioral challenges, dental phobia, or medical conditions, general anesthesia is often required to ensure immobility and cooperation during dental treatments in children. In the clinic where the study will be conducted, the I:E ratio is routinely adjusted approximately 20-30 minutes before the end of the procedure to facilitate a smoother transition to spontaneous breathing during emergence from anesthesia. While 1:2 is commonly used, the 1:3 ratio may improve respiratory efficiency and recovery by prolonging the expiratory phase. The study aims to compare vital signs, respiratory parameters (heart rate, blood pressure, SpO₂, EtCO₂, respiratory rate), recovery quality, and respiratory complications between the two I:E ratios. The findings aim to optimize ventilation strategies and improve patient comfort and safety during emergence from anesthesia.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Apr 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Apr 2026Nov 2026

First Submitted

Initial submission to the registry

November 14, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

8 months

First QC Date

November 14, 2025

Last Update Submit

April 3, 2026

Conditions

Keywords

General AnesthesiaAnesthesia RecoveryEmergence from AnesthesiaMechanical VentilationI:E RatioRecovery Quality

Outcome Measures

Primary Outcomes (5)

  • Post-Extubation Respiratory Quality

    Respiratory quality will be assessed using a study-specific observational scale (range 0-10; higher scores indicate poorer respiratory quality). Components include spontaneous breathing adequacy, accessory muscle use, airway patency, response to painful stimuli, and coughing episodes.

    During 10 minutes after extubation

  • Respiratory Rate (RR)

    Mean respiratory rate (breaths/min) recorded during spontaneous breathing while EtCO₂ is maintained within the standardized target range, for each I:E ratio group (1:2 vs. 1:3).

    During the emergence preparation period (approximately 25-35 minutes prior to extubation, up to 40 minutes if required)

  • Peak Airway Pressure (PeakP)

    Peak airway pressure (cmH₂O) recorded during emergence preparation period for each I:E ratio group (1:2 vs. 1:3).

    During the emergence preparation period (approximately 25-35 minutes prior to extubation, up to 40 minutes if required)

  • Heart Rate

    Mean heart rate (beats/min) recorded during spontaneous breathing while EtCO₂ and sevoflurane MAC are maintained within the standardized target range, for each I:E ratio group (1:2 vs. 1:3).

    During the emergence preparation period (approximately 20-30 minutes prior to extubation, up to 40 minutes if required)

  • Blood Pressure

    Mean arterial blood pressure (mmHg) recorded during spontaneous breathing while EtCO₂ and sevoflurane MAC are maintained within the standardized target range, for each I:E ratio group (1:2 vs. 1:3).

    During the emergence preparation period (approximately 20-30 minutes prior to extubation, up to 40 minutes if required)

Secondary Outcomes (6)

  • Physical Response During Extubation

    From 2 minutes before extubation to 2 minutes after extubation

  • Occurrence of Bronchospasm or Laryngospasm

    From extubation until 30 minutes after extubation

  • Preoperative Anxiety Level Assessed by the Modified Yale Preoperative Anxiety Scale (mYPAS)

    Immediately before surgery (prior to operating room entry)

  • Pediatric Anesthesia Emergence Delirium (PAED) Score

    From emergence from anesthesia through recovery unit stay until discharge, assessed up to 1 hour

  • Modified Aldrete Score

    From emergence from anesthesia through recovery unit stay until discharge, assessed up to 1 hour

  • +1 more secondary outcomes

Study Arms (3)

Group 1: Control

Patients who emerge from anesthesia earlier than planned without pre-emergence preparation. A minimum of 15 patients will be enrolled in this group.

Group 2: I:E 1:2

Patients undergoing standart dental procedures under general anesthesia; during the last phase of the procedure, mechanical ventilation will be applied with an I:E ratio of 1:2. A minimum of 30 patients will be enrolled in this group.

Group 3: I:E 1:3

Patients undergoing standart dental procedures under general anesthesia; during the last phase of the procedure, mechanical ventilation will be applied with an I:E ratio of 1:3. A minimum of 30 patients will be enrolled in this group.

Eligibility Criteria

Age2 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study will include pediatric patients aged 2 to 12 years who are scheduled to undergo routine dental procedures under general anesthesia at our faculty. Eligible participants are classified as American Society of Anesthesiologists (ASA) Physical Status I or II. Patients with airway anomalies, significant adenoid hypertrophy, macroglossia, retrognathia, severe obesity, developmental delays, or a history of delayed emergence from anesthesia will be excluded. Children requiring anesthesia for less than 1 hour or more than 3 hours, those with known pulmonary or airway diseases, neuromuscular disorders affecting respiration, or receiving medications that could alter spontaneous breathing during emergence (e.g., atropine, lidocaine, steroids) are also excluded. Written informed consent must be obtained from parents or legal guardians prior to participation.

You may qualify if:

  • Pediatric patients scheduled for dental procedures under general anesthesia at our faculty.
  • American Society of Anesthesiologists (ASA) Physical Status I or II.
  • Age between 2 and 12 years.
  • Written informed consent obtained from parents or legal guardians.

You may not qualify if:

  • Patients whose parents or legal guardians decline participation.
  • Presence of adenoid hypertrophy \>30%.
  • Macroglossia or retrognathia.
  • Severe obesity or developmental delay.
  • History of delayed emergence from anesthesia.
  • ASA Physical Status III or higher.
  • Anesthesia duration less than 1 hour or more than 3 hours.
  • Patients with difficult airway management or ventilation.
  • Known pulmonary or airway diseases or anomalies.
  • Use of pharmacological agents that may affect spontaneous respiratory quality.
  • Presence of neuromuscular disorders affecting respiratory function.
  • Age \<2 years or \>12 years.
  • Administration of medications intraoperatively or preoperatively that may influence respiratory dynamics during emergence (e.g., atropine, lidocaine, steroids).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kırıkkale University, Faculty of Dentistry

Kırıkkale, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Respiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Gözde Nur Erkan Assisstant Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 14, 2025

First Posted

January 7, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

April 9, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be publicly shared; however, the dataset will be made available upon reasonable request to the corresponding author, subject to approval and relevant ethical considerations.

Locations